Mingzhu Zhu

6PUBLICATIONS
2CO-AUTHORS
Innate immunityInfectious diseasesPredictive and prognostic markersVenereologyClimatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 27, 2026
Validation of a Mucosal IgA Assay for SARS-CoV-2.

|May 27, 2026
Validation of a Pseudovirus Neutralization Assay for Severe Acute Respiratory Syndrome Coronavirus 2 Omicron JN.1 and LP.8.1 Subvariant Lineage Strains with Homologous and Heterologous Matched Sera in Clinically Relevant Samples.

|Nov 27, 2024
A Modified Novel Validated High-Throughput Hemagglutinin Inhibition Assay Using Recombinant Virus-like Particles and Human Red Blood Cells for the Objective Evaluation of Recombinant Hemagglutinin Nanoparticle Seasonal Influenza Vaccine.

Timothy S Vincent, Mingzhu Zhu, Anand Parekh

|Jun 27, 2024
Validation of a Pseudovirus Neutralization Assay for Severe Acute Respiratory Syndrome Coronavirus 2: A High-Throughput Method for the Evaluation of Vaccine Immunogenicity.

Zhaohui Cai, Raj Kalkeri, Mi Wang

|Mar 28, 2024
A Pseudovirus-Based Neutralization Assay for SARS-CoV-2 Variants: A Rapid, Cost-Effective, BSL-2-Based High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation.

Zhaohui Cai, Raj Kalkeri, Mingzhu Zhu

|Jul 29, 2023
A Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Immunoglobulin G Assay: A Robust Method for Evaluation of Vaccine Immunogenicity Using an Established Correlate of Protection.

Mingzhu Zhu, Shane Cloney-Clark, Sheau-Line Feng

Pageof 1

Frequent Collaborators

2 joint publications

Urvashi Patel

1 joint publications

Raj Kalkeri